Curative Biotechnology Stock Short Ratio
| CUBT Stock | USD 0.01 0 13.64% |
Curative Biotechnology fundamentals help investors to digest information that contributes to Curative Biotechnology's financial success or failures. It also enables traders to predict the movement of Curative Stock. The fundamental analysis module provides a way to measure Curative Biotechnology's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Curative Biotechnology stock.
Curative |
Curative Biotechnology Company Short Ratio Analysis
Curative Biotechnology's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, Curative Biotechnology has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The short ratio for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Portfolio Rebalancing Now
Portfolio RebalancingAnalyze risk-adjusted returns against different time horizons to find asset-allocation targets |
| All Next | Launch Module |
Curative Fundamentals
| Return On Equity | -3.98 | |||
| Return On Asset | -0.52 | |||
| Current Valuation | 10.3 M | |||
| Shares Outstanding | 903.26 M | |||
| Shares Owned By Insiders | 0.05 % | |||
| Price To Sales | 158.53 X | |||
| Revenue | 132.32 K | |||
| Gross Profit | 100.21 K | |||
| EBITDA | (2.5 M) | |||
| Net Income | (3.96 M) | |||
| Cash And Equivalents | 126.85 K | |||
| Total Debt | 2.26 M | |||
| Debt To Equity | 6.60 % | |||
| Current Ratio | 0.10 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (486.58 K) | |||
| Earnings Per Share | (0.01) X | |||
| Beta | 214.95 | |||
| Market Capitalization | 9.03 M | |||
| Total Asset | 2.6 M | |||
| Retained Earnings | (38.23 M) | |||
| Working Capital | (4.42 M) | |||
| Net Asset | 2.6 M |
About Curative Biotechnology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Curative Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Curative Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Curative Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Curative Stock Analysis
When running Curative Biotechnology's price analysis, check to measure Curative Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curative Biotechnology is operating at the current time. Most of Curative Biotechnology's value examination focuses on studying past and present price action to predict the probability of Curative Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curative Biotechnology's price. Additionally, you may evaluate how the addition of Curative Biotechnology to your portfolios can decrease your overall portfolio volatility.